V. Molteni et al., Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain, ACT CRYST D, 57, 2001, pp. 536-544
Integration of the reverse-transcribed HIV cDNA into the host DNA is a requ
ired step in viral replication. The virus-encoded integrase protein catalyz
es the initial DNA breaking and joining reactions that mediate cDNA integra
tion. Here, the identification by X-ray crystallography of a small-molecule
binding site on the integrase catalytic domain is reported. The small-mole
cule family studied consists of a core of arsenic or phosphorus surrounded
by four aromatic groups. Two arsenic derivatives were visualized bound to i
ntegrase. In each case, two molecules bound at symmetry-related sites on th
e catalytic domain dimer interface. The first compound studied, tetraphenyl
arsonium, did not inhibit integrase. However, a synthetic compound substit
uting a catechol for one of the phenyl rings, dihydroxyphenyltriphenylarson
ium, bound to the same site and did inhibit the enzyme. Changes in the vici
nity of the catalytic site were seen with the inhibitory compound only, pot
entially explaining its mechanism of action. Further substituting phosphoni
um for arsonium yielded a compound with an IC50 in the low micromolar range
. These findings may be useful in designing new inhibitors of integrase, wh
ich is at present the only one of the three HIV enzymes for which clinicall
y useful inhibitors are not available.